Pregnancy Test Kits Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The pregnancy test kits market size has grown steadily in recent years. It will grow from $1.8 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to antidepressant medications, increased mental health awareness, increased stress levels, access to mental health services, advancements in diagnostic criteria.

The pregnancy test kits market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to emerging pharmacological treatments, telepsychiatry services, focus on comorbidities, global mental health initiatives, pharmacogenomics in treatment, public education programs. Major trends in the forecast period include digital mental health interventions, telemedicine for panic disorder treatment, innovations in medications, neurobiological research, remote monitoring and wearable technology.

The market for pregnancy test kits is anticipated to witness growth due to an escalation in unplanned pregnancies. Unplanned pregnancies, encompassing unwanted or unforeseen conceptions, are driving the demand for pregnancy test kits. These kits, designed to confirm pregnancy, play a pivotal role in determining a woman's pregnancy status, irrespective of the intention behind it. For example, data from March 2022, sourced from the United Nations Population Fund, highlights a global annual incidence of 121 million unintended pregnancies. Moreover, projections for Afghanistan estimate a rise to 4.8 million unintended pregnancies by 2025. Thus, the surge in unplanned pregnancies is poised to fuel the pregnancy test kits market.

The increase in fertility rates is expected to drive the growth of the pregnancy test kits market. As fertility rates rise, more women are attempting to conceive, leading to a higher demand for pregnancy test kits. These kits provide a simple and convenient way for women to confirm pregnancy, offering a direct indicator of fertility and successful conception. For example, according to the Australia Bureau of Statistics, births registered in 2023 saw an increase of 349 compared to 2022, reaching a total of 24,737 births, which represents 8.6% of all births registered. This growth in fertility rates directly influences the demand for pregnancy test kits, contributing to market expansion.

Innovative product development, exemplified by at-home test kits such as PregaScreen, is a strategic move by leading companies aiming to augment their market share in the pregnancy test kits industry. PregaScreen, an at-home pregnancy test kit introduced by Mylab Discovery Solutions Pvt. Ltd., detects human chorionic gonadotropin (hCG) in urine accurately when used correctly. In June 2022, Mylab Discovery Solutions Pvt. Ltd. launched PregaScreen, ensuring women can independently determine their pregnancy status with precise results in minutes, boasting an impressive 99.99% accuracy rate. Each kit comprises a pregnancy stick and a dropper, providing a convenient testing solution for women seeking to confirm pregnancy after a missed menstrual period.

In July 2024, Mankind Pharma Ltd., an India-based pharmaceutical company, acquired Bharat Serums and Vaccines Limited for a reported amount of $1.5 billion. This acquisition allows Mankind Pharma Ltd. to strengthen its product portfolio and expand its market presence in the pharmaceutical industry. Bharat Serums and Vaccines Limited, an Indian-based biopharmaceutical company, is known for manufacturing pregnancy test kits, which will further complement Mankind Pharma's existing offerings and help it tap into the growing demand for such products in the market.

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

North America was the largest region in the pregnancy test kits market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnancy test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pregnancy test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pregnancy test kits market consists of sales of kits such as test cassette format, test strip format, and test midstream format kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A pregnancy test kit serves as a diagnostic tool to determine the presence of pregnancy in women. These kits employ urine samples to detect the hormone Human Chorionic Gonadotropin (hCG), which is produced by the placenta during pregnancy.

The primary categories of pregnancy test kits include blood tests for HCG and urine tests for HCG. Blood tests for HCG involve clinical assessments to measure the concentration of the human chorionic gonadotropin (HCG) hormone in the bloodstream. These kits are distributed through retail and online channels, catering to various settings such as hospitals, clinics, households, and pharmacies. The end users include both professionals and individuals using the kits at home.

The pregnancy test kits market research report is one of a series of new reports that provides pregnancy test kits market statistics, including pregnancy test kits industry global market size, regional shares, competitors with a pregnancy test kits market share, detailed pregnancy test kits market segments, market trends and opportunities, and any further data you may need to thrive in the pregnancy test kits industry. This pregnancy test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.